KCT0005856尚未招募未知
Repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence without distant metastasis: A single-arm, multicenter, prospective study
Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 532 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 532
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- Female
入选标准
- •1) Age over 19 years old
- •2) Patients who are expected to undergo surgery under the diagnosis of ipsilateral breast tumor recurrence(histologically confirmed in situ disease or invasive disease)
- •3) Patients who had partial mastectomy and sentinel lymph node biopsy for prior operation for the initially diagnosed breast cancer
- •4) Patients considered to be axillary lymph node negative from clinical findings
- •5) Patients who understand and willingly participate in the study
排除标准
- •1) Patients with recurrence in other regions. (e.g. ipsilateral axillary lymph node, supraclavicular lymph node, internal mammary lymph node, etc.)
- •2) Patients who are not eligible to perform SLNB
- •3) Patients who received mastectomy or axillary lymph node dissection for prior operation
- •4) Patients who experienced recurrence within a year from the primary operation
- •5) Patientes who are known to have axillary lymph node metastasis before the secondary operation, histologically confirmed from tissue biopsy or cytology
- •6) Patients with systemic recurrence
- •7) Patients with inflammatory breast cancer
- •8) Pregnant and lactating patients
研究者
相似试验
进行中（未招募）
1 期
Clinical trial to purchase the effect of supplementation with intravenous fish oil on the evolution of esophagectomized patientsEUCTR2016-004978-17-ESHospital Universitari Bellvitge
进行中（未招募）
1 期
A clinical trial for a guided early administration of antibiotics for presumed infection at the EREUCTR2018-001008-13-GRHELLENIC INSTITUTE FOR THE STUDY OF SEPSIS220
已完成
不适用
REVISED CLINICAL PROTOCOL FOR A RANDOMIZED, DOUBLE-BLIND, CONTROLLED BY PLACEBO, STUDY TO COMPARE THE ANALGESIC ACTIVITY OF VALDECOXIB (SC-65872) 40 MG TWICE PER DAY AS ADDITIVE MEDICATION THERAPY OPIATES IN PATIENTS WITH CHRONIC CANCER PAI-R522 Other chronic painOther chronic painR522PER-058-01PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
进行中（未招募）
不适用
Double-Blind Extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of converting to MS, treated with rebif New Formulation (REFLEXION) - REFLEXIOEUCTR2008-004954-34-ITMERCK SERONO SA492
进行中（未招募）
不适用
An optional continuation of double-blind treatment for subjects who have achieved good symptom control with stable prednisone dosing and who have completed Protocol WX17798 A prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter, 36-week trial to assess the efficacy and safety of adjunct mycophenolate mofetil MMF to maintain or improve symptom control with reduced corticosteroids in subjects with myasthenia gravis - NDMedDRA version: 6.1Level: PTClassification code 10028417Myasthenia GravisEUCTR2005-000343-28-ITASPREVA PHARMACEUTICALS CORPORATIO136